The patterns and burden of multimorbidity in geriatric patients with prolonged use of addictive medications
Permanent link
https://hdl.handle.net/10037/21873Date
2021-02-18Type
Journal articleTidsskriftartikkel
Peer reviewed
Author
Cheng, Socheat; Siddiqui, Tahreem Ghazal; Gossop, Michael; Wyller, Torgeir Bruun; Kristoffersen, Espen Saxhaug; Lundqvist, Anders ChristoferAbstract
Background - Multimorbidity and prolonged use of addictive medications are prevalent among older patients, and known to increase the risk of adverse drug events. Yet, the relationship between these two entities has remained understudied.
Aims - This study explored the association between multimorbidity burden and prolonged use of addictive medications in geriatric patients, adjusted for clinically important covariates. Furthermore, we identified comorbidity patterns in prolonged users.
Methods - We conducted a cross-sectional study on a consecutive sample of 246 patients, aged 65–90 years, admitted to a large public university hospital in Norway. We defined prolonged use of addictive medications as using benzodiazepines, opioids and/or z-hypnotics beyond the duration recommended by clinical guidelines (≥ 4 weeks). Multimorbidity was assessed with the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), based on diagnoses made by independent physicians.
Results - Compared to non-prolonged use, prolonged use was significantly more common among patients who had psychiatric (19/27, 70%), liver (19/22, 86%), upper gastrointestinal tract (21/32, 66%), musculoskeletal (52/96, 54%), or nervous system disorders (46/92, 50%). Patients with prolonged use had a higher multimorbidity burden than those without such use (CIRS-G score, mean = 7.7, SD = 2.7 versus mean = 4.6, SD = 2.2, p < 0.001). Multivariable logistic regression indicated a significant association between multimorbidity burden and prolonged addictive medication use (OR = 1.72, 95% CI 1.42–2.08). Predictive margins postestimation showed a systematic increase in the predicted CIRS-G scores when the number of addictive drug used increases.
Conclusions - Multimorbidity is strongly associated with prolonged use of addictive medications. Multiple substance use may aggravate disease burden of older patients.
Aims - This study explored the association between multimorbidity burden and prolonged use of addictive medications in geriatric patients, adjusted for clinically important covariates. Furthermore, we identified comorbidity patterns in prolonged users.
Methods - We conducted a cross-sectional study on a consecutive sample of 246 patients, aged 65–90 years, admitted to a large public university hospital in Norway. We defined prolonged use of addictive medications as using benzodiazepines, opioids and/or z-hypnotics beyond the duration recommended by clinical guidelines (≥ 4 weeks). Multimorbidity was assessed with the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), based on diagnoses made by independent physicians.
Results - Compared to non-prolonged use, prolonged use was significantly more common among patients who had psychiatric (19/27, 70%), liver (19/22, 86%), upper gastrointestinal tract (21/32, 66%), musculoskeletal (52/96, 54%), or nervous system disorders (46/92, 50%). Patients with prolonged use had a higher multimorbidity burden than those without such use (CIRS-G score, mean = 7.7, SD = 2.7 versus mean = 4.6, SD = 2.2, p < 0.001). Multivariable logistic regression indicated a significant association between multimorbidity burden and prolonged addictive medication use (OR = 1.72, 95% CI 1.42–2.08). Predictive margins postestimation showed a systematic increase in the predicted CIRS-G scores when the number of addictive drug used increases.
Conclusions - Multimorbidity is strongly associated with prolonged use of addictive medications. Multiple substance use may aggravate disease burden of older patients.
Publisher
SpringerCitation
Cheng, Siddiqui, Gossop, Wyller, Kristoffersen, Lundqvist. The patterns and burden of multimorbidity in geriatric patients with prolonged use of addictive medications. Aging Clinical and Experimental Research. 2021Metadata
Show full item recordCollections
Copyright 2021 The Author(s)
Related items
Showing items related by title, author, creator and subject.
-
Influence of environmental tonicity changes on lipophilic drug release from liposomes
Nikolaisen, Trygg Einar (Mastergradsoppgave; Master thesis, 2018-05-15)Introduction: Liposomes as drug delivery systems has been widely studied as a way to solubilize poorly soluble drugs, reduce side effects of chemotherapeutics and increase circulation time in vivo. Since the first descriptions of liposomes over 60 years ago, they have shown tendencies to shrink and swell when the external environment of the liposomes is altered. This phenomenon has been studied in ... -
Implementing an electronic health record in a Nigerian secondary healthcare facility. Prospects and challenges
Attah, Ambrose Ojadale (Master thesis; Mastergradsoppgave, 2017-11-02)Nigeria is witnessing continuing advocacy and increase in number of individuals yearning for computerization of health information and healthcare processes. However, little is known about the opinions of the diverse healthcare providers who would ensure the successful implementation and meaningful use of health information technology in the country (Adeleke, Erinle et al. 2015). This study explores ... -
Geometric Modeling- and Sensor Technology Applications for Engineering Problems
Pedersen, Aleksander (Doctoral thesis; Doktorgradsavhandling, 2020-10-20)In applications for technical problems, Geometric modeling and sensor technology are key in both scientific and industrial development. Simulations and visualization techniques are the next step after defining geometry models and data types. This thesis attempts to combine different aspects of geometric modeling and sensor technology as well as to facilitate simulation and visualization. It includes ...